Renal arterial infusion of BQ123 blunted the vasoconstrictor response to ET-1 but did not affect urine production or free water clearance in conscious sheep.
The ETA receptor antagonist BQ123 blocks ET-1 induced renal vasoconstriction but not diuresis, suggesting these effects are mediated by different receptor mechanisms.
The effect of cyclo(D-Trp-D-Asp-Pro-D-Val-Leu) (or BQ123), a selective ETA receptor antagonist, on the vasoconstrictor and diuretic responses elicited by endothelin-1 (ET-1) was examined in conscious sheep with chronic indwelling renal arterial cannulae. 2. Using low dose close renal arterial infusion, ET-1 has potent effects on the kidney causing a marked decrease in effective renal plasma flow and an increase in urine output and free water clearance in the normally hydrated animal. 3. The vasoconstrictor response to renal arterial infusion of ET-1 at 5 micrograms/h was blunted by renal arterial infusion of the ETA receptor selective antagonist, BQ123 (400 micrograms/h). 4. In contrast, the effect of ET-1 on urine production and free water clearance was not affected by this dose of BQ123. 5. The differential effect of BQ123 on renal blood flow and urine production suggests that these effects of endothelin on the kidney are mediated through different receptor mechanisms.
Kamphuis et al. (1994) studied this question. BQ123 was evaluated on vasoconstrictor and diuretic responses to endothelin-1. Renal arterial infusion of BQ123 blunted the vasoconstrictor response to ET-1 but did not affect urine production or free water clearance in conscious sheep.